ESLA Estrella Immunopharma, Inc.: institutional ownership and insider trading
18 funds reported holding $5.74M of Estrella Immunopharma, Inc. in their latest 13F filings; in Q2 2026 funds net sold $400K, with 2 new positions and 3 funds selling out; over the last 12 months insiders bought $0 and sold $0 on the open market.
Famous investors holding ESLA
- Renaissance Technologies (Renaissance Technologies): $40.7K, 0.0% of the portfolio
Largest institutional holders of ESLA
- ARMISTICE CAPITAL, LLC — $4.13M
- VANGUARD GROUP INC — $700K
- VANGUARD CAPITAL MANAGEMENT LLC — $434K
- GEODE CAPITAL MANAGEMENT, LLC — $147K
- VANGUARD FIDUCIARY TRUST CO — $67.5K
- BlackRock, Inc. (BLK) — $54.1K
- ATW SPAC MANAGEMENT LLC — $46.0K
- STATE STREET CORP (STT, STT-PG) — $45.0K
- RENAISSANCE TECHNOLOGIES LLC — $40.7K
- NORTHERN TRUST CORP (NTRS, NTRSO) — $36.3K
Recent ESLA insider trades
- Oct 7, 2025: Xu Jiandong bought 2,100 shares ($2.59K)